Introduction to the Cardio-Oncology Miniseries.

Abstract

HomeCirculationVol. 132, No. 19Introduction to the Cardio-Oncology Miniseries Free AccessResearch ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessResearch ArticlePDF/EPUBIntroduction to the Cardio-Oncology Miniseries Ravin Davidoff, MBBCh, Michael Fifer, MD and Sanjeev Francis, MD Ravin DavidoffRavin Davidoff Search for more papers by this author , Michael FiferMichael Fifer Search for more papers by this author and Sanjeev FrancisSanjeev Francis Search for more papers by this author Originally published10 Nov 2015https://doi.org/10.1161/CIRCULATIONAHA.115.019806Circulation. 2015;132:1834The intersection of cancer and cardiovascular disease occurs on several levels. The present miniseries, within Circulation’s Contemporary Reviews in Cardiovascular Medicine series, will highlight important areas within the emerging discipline of cardio-oncology. The miniseries will straddle a number of topics, as outlined below.The relationship of traditional cardiovascular risk factors with the development of cancer. This is a unique area within cardio-oncology that has not been fully covered in the current literature.The link between targeted chemotherapeutics and cardiac, vascular, and metabolic diseases with an emphasis on the molecular mechanisms. This has become an increasingly relevant area, given the rapid development and growth of this class of therapies.The clinically important area of cardioprotection during chemotherapy and the current data and areas that require additional research.A comprehensive review of the cardiovascular risks faced by cancer survivors and a concise review of current guidelines and areas of uncertainty for the practicing clinician.This miniseries will provide an in-depth review for the practicing clinician (cardiologist, oncologist, and internist) and provide insights, for the physician-scientist and scientist, into the mechanistic link between cancer and cardiovascular biology afforded by examining the cardiovascular impact of targeted cancer therapies and the impact of cardiovascular risk factors and medications in cancer biology.Ravin Davidoff, MBBChMichael Fifer, MDSanjeev Francis, MD Previous Back to top Next FiguresReferencesRelatedDetailsCited ByZaha V, Hundley W and Hill J (2018) Cardio-Oncology, Circulation, 138:7, (663-665), Online publication date: 14-Aug-2018. Sueta D, Tabata N, Akasaka T, Yamashita T, Ikemoto T and Hokimoto S (2016) The dawn of a new era in onco-cardiology: The Kumamoto Classification, International Journal of Cardiology, 10.1016/j.ijcard.2016.06.330, 220, (837-841), Online publication date: 1-Oct-2016. November 10, 2015Vol 132, Issue 19 Advertisement Article InformationMetrics © 2015 American Heart Association, Inc.https://doi.org/10.1161/CIRCULATIONAHA.115.019806PMID: 26553712 Originally publishedNovember 10, 2015 PDF download Advertisement SubjectsHeart Failure